The contribution of GPCRs to thymocyte medullary entry and central tolerance
GPCR 对胸腺细胞髓质进入和中枢耐受的贡献
基本信息
- 批准号:8629092
- 负责人:
- 金额:$ 37.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-03-15 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:AffectAffinityAntigen ReceptorsAntigensApoptosisAtypical lymphocyteAutoantigensAutoimmune DiseasesAutoimmune ProcessAutoimmunityAutomobile DrivingCD8B1 geneCandidate Disease GeneCellsDefectDendritic CellsDiseaseEnsureEpithelial CellsEtiologyExpression LibraryFlow CytometryG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGene RearrangementGenesGeneticGenetic RecombinationGoalsHumanImageImmune responseIndividualKnockout MiceLeftLifeLocationMaintenanceMajor Histocompatibility ComplexMicroscopyModelingMolecularMolecular ProfilingMouse StrainsMusNatureOpen Reading FramesOrganPatientsPeripheralProcessProductionProteinsRoleSelf ToleranceSliceStromal CellsSyndromeT-Cell Antigen Receptor SpecificityT-Cell DevelopmentT-Cell ReceptorT-LymphocyteTestingThymic epithelial cellThymus GlandTransgenic Organismsbasecell motilitycentral tolerancecombinatorialdefined contributiongain of functionmigrationmouse modelnovelnovel therapeuticspathogenpreventpublic health relevancereceptorthymocytetwo-photon
项目摘要
DESCRIPTION (provided by applicant): In this project we propose to determine the role of candidate G protein-coupled receptors (GPCRs) in enforcing deletion of developing auto-reactive T cells in the thymus. In order for T cells to recognize and respond to the wide array of pathogens encountered throughout life, each cell expresses a unique antigen receptor, the T cell receptor (TCR), that is capable of recognizing and responding to individual pathogens. These vastly diverse receptors are generated by random and imprecise rearrangements of gene segments encoding the TCR. Unfortunately, this random recombination process also yields autoreactive TCRs that could induce autoimmune diseases. To prevent overt autoimmunity, developing T cells are educated in the thymus through interactions with thymic stromal cells: thymocytes expressing overtly autoreactive TCRs are induced to undergo apoptosis. This process of thymic self-tolerance induction is referred to as central tolerance. Central tolerance i imposed largely within the interior, medullary region of the thymus, where thymocytes encounter a wide array of self-antigens expressed on stromal cells, namely dendritic cells and/or medullary thymic epithelial cells. It is critical that developing thymocytes enter the medulla and interact with stromal cells therein to eliminate autoreactive cells. From studies of Autoimmune Polyglandular Syndrome-I patients along with mouse models of this disorder, we know that if central tolerance induction in the medulla is impaired, multi-organ autoimmunity ensues. Based on our previous studies, GPCR signaling is required for thymocyte medullary entry. In this proposal, the role of candidate GPCRs in promoting medullary entry and self-tolerance will be evaluated. Using 2-photon microscopy, live thymocytes deficient for candidate GPCRs will be imaged to determine whether their ability to enter the medulla or to interact with medullary stromal cells is impaired. In a complementary set of traditional immunological approaches, murine models deficient for candidate GPCRs will be tested for overt autoimmunity, as well as for an inability to induce central tolerance to model medullary self- antigens. Finally, unbiased gain-of-function screens will identify additional molecular candidates that promote thymocyte medullary entry and self-tolerance. These studies will illuminate molecular mechanisms that promote thymocyte migration into the medulla and interactions with medullary stromal cells to promote central tolerance, thus broadening our understanding of the etiology of autoimmune diseases.
描述(由申请人提供):在此项目中,我们建议确定候选G蛋白偶联受体(GPCR)在实施胸腺中产生自身反应性T细胞的缺失中的作用。为了使T细胞能够识别并应对一生中遇到的各种病原体,每个细胞表达一个独特的抗原受体T细胞受体(TCR),该受体能够识别和应对单个病原体。这些大量的受体是由编码TCR的基因段的随机和不精确的重排产生的。不幸的是,这种随机重组过程还产生了自身反应性TCR,可能诱发自身免疫性疾病。为了防止明显的自身免疫性,通过与胸腺基质细胞的相互作用在胸腺中教育发育中的T细胞:表达公开自身反应性TCR的胸腺细胞被诱导出现凋亡。胸腺自我耐受诱导的这一过程称为中心耐受性。中央耐受性I主要在胸腺内部的髓质区域内施加,胸腺细胞遇到在基质细胞上表达的广泛的自我抗原,即树突状细胞和/或髓质胸皮上皮细胞。至关重要的是,开发胸腺细胞进入髓质并与其中的基质细胞相互作用以消除自动反应性细胞。从对自身免疫性多边形综合征-I患者以及该疾病的小鼠模型的研究,我们知道,如果延髓中的中央耐受性诱导会受到损害,则随之而来的是多器官自身免疫。根据我们以前的研究,胸腺细胞髓质进入需要GPCR信号传导。在此提案中,将评估候选GPCR在促进髓质进入和自我宽容中的作用。使用2光子显微镜,将成像缺乏候选GPCR的活胸腺细胞,以确定其进入髓质的能力是否会受损或与髓质基质细胞相互作用。在一系列互补的传统免疫学方法中,将测试缺乏候选GPCR的鼠模型,以实现明显的自身免疫性,以及无法诱导中央耐受性以模拟髓质自我抗原。最后,无偏的功能屏幕将确定促进胸腺细胞髓质进入和自我耐受性的其他分子候选物。这些研究将阐明分子机制,这些机制促进胸腺细胞迁移到髓质中,并与髓质基质细胞相互作用以促进中心耐受性,从而扩大我们对自身免疫性疾病病因的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lauren Ilyse Richie EHRLICH其他文献
Lauren Ilyse Richie EHRLICH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lauren Ilyse Richie EHRLICH', 18)}}的其他基金
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
CCR4 与 CCR7 对胸腺细胞定位和中枢耐受的独特贡献
- 批准号:
10200461 - 财政年份:2020
- 资助金额:
$ 37.32万 - 项目类别:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
项目 3 - 胸腺 APC 在围产期到成人过渡期间对中枢耐受的不同贡献
- 批准号:
10022939 - 财政年份:2020
- 资助金额:
$ 37.32万 - 项目类别:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
项目 3 - 胸腺 APC 在围产期到成人过渡期间对中枢耐受的不同贡献
- 批准号:
10251300 - 财政年份:2020
- 资助金额:
$ 37.32万 - 项目类别:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
项目 3 - 胸腺 APC 在围产期到成人过渡期间对中枢耐受的不同贡献
- 批准号:
10470932 - 财政年份:2020
- 资助金额:
$ 37.32万 - 项目类别:
Project 3 - Differential contribution of thymic APCs to central tolerance during the perinatal to adult transition
项目 3 - 胸腺 APC 在围产期到成人过渡期间对中枢耐受的不同贡献
- 批准号:
10689304 - 财政年份:2020
- 资助金额:
$ 37.32万 - 项目类别:
Role of the microenvironment in regulating early stages of thymic involution and central tolerance
微环境在调节胸腺复旧和中枢耐受早期阶段的作用
- 批准号:
10553994 - 财政年份:2017
- 资助金额:
$ 37.32万 - 项目类别:
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
CCR4 与 CCR7 对胸腺细胞定位和中枢耐受的独特贡献
- 批准号:
10411920 - 财政年份:2014
- 资助金额:
$ 37.32万 - 项目类别:
Distinct contributions of CCR4 versus CCR7 to thymocyte localization and central tolerance
CCR4 与 CCR7 对胸腺细胞定位和中枢耐受的独特贡献
- 批准号:
10265640 - 财政年份:2014
- 资助金额:
$ 37.32万 - 项目类别:
The contribution of GPCRs to thymocyte medullary entry and central tolerance
GPCR 对胸腺细胞髓质进入和中枢耐受的贡献
- 批准号:
8820882 - 财政年份:2014
- 资助金额:
$ 37.32万 - 项目类别:
The contribution of GPCRs to thymocyte medullary entry and central tolerance
GPCR 对胸腺细胞髓质进入和中枢耐受的贡献
- 批准号:
9011993 - 财政年份:2014
- 资助金额:
$ 37.32万 - 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Targeting HNF4-induced thrombo-inflammation in Chagas disease
针对恰加斯病中 HNF4 诱导的血栓炎症
- 批准号:
10727268 - 财政年份:2023
- 资助金额:
$ 37.32万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 37.32万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 37.32万 - 项目类别:
Regulation of eDHFR-tagged proteins with trimethoprim PROTACs
使用甲氧苄啶 PROTAC 调节 eDHFR 标记蛋白
- 批准号:
10714294 - 财政年份:2023
- 资助金额:
$ 37.32万 - 项目类别: